Last updated: 7 May 2024 at 5:10pm EST

Carolyn Tastad Net Worth




The estimated Net Worth of Carolyn M Tastad is at least $40.8 Millón dollars as of 1 March 2022. Ms. Tastad owns over 3,730 units of Procter & Gamble Co stock worth over $4,896,892 and over the last 11 years she sold PG stock worth over $29,067,132. In addition, she makes $6,851,060 as Group President - North America and Chief Sales Officer at Procter & Gamble Co.

Ms. Tastad PG stock SEC Form 4 insiders trading

Carolyn has made over 53 trades of the Procter & Gamble Co stock since 2014, according to the Form 4 filled with the SEC. Most recently she sold 3,730 units of PG stock worth $572,592 on 1 March 2022.

The largest trade she's ever made was exercising 51,867 units of Procter & Gamble Co stock on 27 October 2020 worth over $3,912,328. On average, Carolyn trades about 4,817 units every 31 days since 2014. As of 1 March 2022 she still owns at least 28,156 units of Procter & Gamble Co stock.

You can see the complete history of Ms. Tastad stock trades at the bottom of the page.





Carolyn Tastad biography

Carolyn M. Tastad is Group President - North America and Chief Sales Officer of the Company. Ms. Tastad began her P&G career in 1983. She has deep experience leading sales and market development organizations for P&G businesses in the U.S., Canada, Europe and globally, and has worked in a range of businesses including deep experience in Health and Beauty.

What is the salary of Carolyn Tastad?

As the Group President - North America and Chief Sales Officer of Procter & Gamble Co, the total compensation of Carolyn Tastad at Procter & Gamble Co is $6,851,060. There are 3 executives at Procter & Gamble Co getting paid more, with David Taylor having the highest compensation of $22,905,100.



How old is Carolyn Tastad?

Carolyn Tastad is 58, she's been the Group President - North America and Chief Sales Officer of Procter & Gamble Co since 2019. There are 16 older and 18 younger executives at Procter & Gamble Co. The oldest executive at Procter & Gamble Co. is Nelson Peltz, 78, who is the Independent Director.

What's Carolyn Tastad's mailing address?

Carolyn's mailing address filed with the SEC is 412 N. WELLS STREET, , CHICAGO, IL, 60654.

Insiders trading at Procter & Gamble Co

Over the last 19 years, insiders at Procter & Gamble Co have traded over $3,894,676,988 worth of Procter & Gamble Co stock and bought 6,769 units worth $466,837 . The most active insiders traders include Nelsontrian Fund Management..., Margaret C Whitman y Scott D Cook. On average, Procter & Gamble Co executives and independent directors trade stock every 5 days with the average trade being worth of $7,758,919. The most recent stock trade was executed by Jon R Moeller on 28 August 2024, trading 37,240 units of PG stock currently worth $6,289,464.



What does Procter & Gamble Co do?

The Procter & Gamble Company is an American multinational consumer goods corporation headquartered in Cincinnati, Ohio, founded in 1837 by William Procter and James Gamble.



Complete history of Ms. Tastad stock trades at Kellanova Co y Procter & Gamble Co

Persona
Trans.
Transacción
Precio total
Carolyn M Tastad
CEO - Health Care
Venta $572,592
1 Mar 2022
Carolyn M Tastad
CEO - Health Care
Uso de opción $9,338
6 Dec 2021
Carolyn M Tastad
CEO - Health Care
Venta $4,056,985
17 Aug 2021
Carolyn M Tastad
CEO - Health Care
Venta $1,101,836
2 Aug 2021
Carolyn M Tastad
CEO - Health Care
Venta $414,600
26 May 2021
Carolyn M Tastad
CEO - Health Care
Venta $482,230
11 May 2021
Carolyn M Tastad
CEO - Health Care
Venta $991,068
26 Feb 2021
Carolyn M Tastad
CEO - Health Care
Uso de opción $9,220
15 Dec 2020
Carolyn M Tastad
CEO - Health Care
Uso de opción $3,912,328
27 Oct 2020
Carolyn M Tastad
CEO - Health Care
Venta $4,887,833
18 Aug 2020
Carolyn M Tastad
CEO - Health Care
Venta $1,224,080
31 Jul 2020
Carolyn M Tastad
CEO - Health Care
Venta $803,559
27 Feb 2020
Carolyn M Tastad
CEO - Health Care
Uso de opción $2,943,695
28 Jan 2020
Carolyn M Tastad
CEO - Health Care
Uso de opción $7,805
20 Nov 2019
Carolyn M Tastad
CEO - Health Care
Venta $1,258,116
26 Aug 2019
Carolyn M Tastad
CEO - Health Care
Venta $1,128,995
20 Aug 2019
Carolyn M Tastad
CEO - Health Care
Uso de opción $1,746,168
22 May 2019
Carolyn M Tastad
CEO - Health Care
Venta $421,283
1 May 2019
Carolyn M Tastad
CEO - Health Care
Venta $147,165
28 Feb 2019
Carolyn M Tastad
CEO - Health Care
Uso de opción $1,249,208
28 Nov 2018
Carolyn M Tastad
CEO - Health Care
Uso de opción $44,296
20 Nov 2018
Carolyn M Tastad
CEO - Health Care
Venta $580,410
15 Nov 2018
Carolyn M Tastad
CEO - Health Care
Uso de opción $558,273
14 Nov 2018
Carolyn M Tastad
CEO - Health Care
Venta $349,197
22 Aug 2018
Carolyn M Tastad
CEO - Health Care
Uso de opción $5,617
6 Aug 2018
Carolyn M Tastad
CEO - Health Care
Venta $2,684,940
1 Aug 2018
Carolyn M Tastad
CEO - Health Care
Venta $152,730
15 Nov 2017
Carolyn M Tastad
CEO - Health Care
Venta $472,654
30 Sep 2017
Carolyn M Tastad
CEO - Health Care
Venta $158,125
15 Aug 2017
Carolyn M Tastad
CEO - Health Care
Venta $158,125
15 Aug 2017
Carolyn M Tastad
CEO - Health Care
Uso de opción $5,204
7 Aug 2017
Carolyn M Tastad
CEO - Health Care
Uso de opción $5,204
7 Aug 2017
Carolyn M Tastad
CEO - Health Care
Venta $88,008
15 Feb 2017
Carolyn M Tastad
CEO - Health Care
Venta $88,008
15 Feb 2017
Carolyn M Tastad
CEO - Health Care
Venta $143,559
2 Nov 2016
Carolyn M Tastad
CEO - Health Care
Venta $143,559
2 Nov 2016
Carolyn M Tastad
CEO - Health Care
Venta $2,659,272
30 Sep 2016
Carolyn M Tastad
CEO - Health Care
Venta $2,659,272
30 Sep 2016
Carolyn M Tastad
CEO - Health Care
Venta $120,216
16 Aug 2016
Carolyn M Tastad
CEO - Health Care
Venta $153,113
27 May 2016
Carolyn M Tastad
CEO - Health Care
Venta $97,047
29 Feb 2016
Carolyn M Tastad
CEO - Health Care
Uso de opción $1,201,040
8 Feb 2016
Carolyn M Tastad
CEO - Health Care
Uso de opción $334,706
1 Feb 2016
Carolyn M Tastad
CEO - Health Care
Venta $753
1 Dec 2015
Carolyn M Tastad
CEO - Health Care
Uso de opción $519
30 Nov 2015
Carolyn M Tastad
CEO - Health Care
Uso de opción $3,932
6 Aug 2015
Carolyn M Tastad
CEO - Health Care
Venta $168,738
20 May 2015
Carolyn M Tastad
CEO - Health Care
Venta $128,557
26 Feb 2015
Carolyn M Tastad
CEO - Health Care
Venta $191,493
6 Nov 2014
Carolyn M Tastad
CEO - Health Care
Uso de opción $948,834
29 Aug 2014
Carolyn M Tastad
CEO - Health Care
Uso de opción $2,660
7 Aug 2014
Carolyn M Tastad
CEO - Health Care
Venta $220,508
1 May 2014
Carolyn M Tastad
CEO - Health Care
Venta $158,508
27 Feb 2014


Procter & Gamble Co executives and stock owners

Procter & Gamble Co executives and other stock owners filed with the SEC include: